Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PTC THERAPEUTICS, INC.PTCT · Entity 3803 | CHIEF BUSINESS OFFICER | June 10, 2026 | June 12, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PTC THERAPEUTICS, INC.
Report date June 10, 2026 · Filed June 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 73,411 |
Ending reported balance
After 2026-06-10 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2026-06-10 · Sale · Disposed 3,711 · Balance 73,411 F1: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 25, 2026. Row 2 · 2026-06-10 · Exercise / conversion · Acquired 17,566 · Balance 90,977 F1: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 25, 2026. Row 3 · 2026-06-10 · Sale · Disposed 17,566 · Balance 73,411 F1: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 25, 2026. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $18.01 · Expires 2028-01-02 | Direct | 0 |
Reported balance
After 2026-06-10 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-06-10 · Sale · Disposed 17,566 · Balance 0 F1: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 25, 2026. F2: Currently exercisable. |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 25, 2026.
F2: Currently exercisable.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 05, 2023 Filed Jan 9, 2023 21:54 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | GrantCommon Stock | 18,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-000690 · form4-01092023_090159.xml · nonDerivative · entry 1 Pauwels Eric · CIK 0001323212 · CHIEF BUSINESS OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,363 F1 · shares: Restricted stock units granted on January 5, 2023 that vest in four equal installments over four years, commencing on January 5, 2024. F2 · balance_after: Includes 293 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2022 and 298 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2022. Read SEC document |
| April 19, 2022 Filed Apr 21, 2022 20:02 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 822 | $42.52 | $34,947.33 |
DisclosureSEC source: 0001415889-22-004210 · form4-04212022_010437.xml · nonDerivative · entry 1 Pauwels Eric · CIK 0001323212 · CHIEF BUSINESS OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,772 F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 2,500 RSUs from a April 16, 2020 grant of 10,000 RSUs. Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 21:58 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 367 | $40.00 | $14,680.73 |
DisclosureSEC source: 0001179110-22-000839 · edgar.xml · nonDerivative · entry 1 Pauwels Eric · CIK 0001323212 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,594 F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 1,198 RSUs from a January 29, 2020 grant of 4,790 RSUs. Read SEC document |
| January 25, 2022 Filed Jan 27, 2022 21:02 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 359 | $39.31 | $14,113.73 |
DisclosureSEC source: 0001179110-22-000630 · edgar.xml · nonDerivative · entry 1 Pauwels Eric · CIK 0001323212 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,961 F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 1,155 shares of restricted stock from a January 22, 2019 grant of 4,620 shares of restricted stock. Read SEC document |
| January 07, 2022 Filed Jan 11, 2022 21:17 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | GrantStock Option (Right to Buy) · Derivative | 63,000 | $0.00 Strike: $38.10 | $0.00 |
DisclosureSEC source: 0001179110-22-000395 · edgar.xml · derivative · entry 3 Pauwels Eric · CIK 0001323212 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,000 Underlying: Common Stock · 63,000 shares Expires 2032-01-06 F3 · derivative.exercise_date: This option was granted on January 7, 2022, and vests over four years, with 25% of the shares underlying the option vesting on January 7, 2023, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 7, 2023. Read SEC document |
| January 07, 2022 Filed Jan 11, 2022 21:17 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | GrantCommon Stock | 16,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-000395 · edgar.xml · nonDerivative · entry 2 Pauwels Eric · CIK 0001323212 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,320 F2 · shares: Restricted stock units granted on January 7, 2022 that vest in four equal installments over four years, commencing on January 7, 2023. Read SEC document |
| January 07, 2022 Filed Jan 11, 2022 21:17 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 866 | $38.53 | $33,362.65 |
DisclosureSEC source: 0001179110-22-000395 · edgar.xml · nonDerivative · entry 1 Pauwels Eric · CIK 0001323212 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,520 F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 2,550 RSUs from a January 6, 2021 grant of 10,200 RSUs. Read SEC document |
| January 04, 2022 Filed Jan 6, 2022 21:09 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 806 | $41.16 | $33,176.57 |
DisclosureSEC source: 0001179110-22-000301 · edgar.xml · nonDerivative · entry 1 Pauwels Eric · CIK 0001323212 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,386 F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 2,300 shares of restricted stock from a January 3, 2018 grant of 9,200 shares of restricted stock. F2 · balance_after: Includes 206 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2021 and 285 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2021. Read SEC document |
| April 19, 2021 Filed Apr 21, 2021 20:12 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 786 | $48.17 | $37,860.05 |
DisclosureSEC source: 0001179110-21-004536 · edgar.xml · nonDerivative · entry 1 Pauwels Eric · CIK 0001323212 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,701 F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 2,500 RSUs from a April 16, 2020 grant of 10,000 RSUs. Read SEC document |
| February 01, 2021 Filed Feb 2, 2021 23:21 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 362 | $56.96 | $20,618.07 |
DisclosureSEC source: 0001179110-21-001093 · edgar.xml · nonDerivative · entry 1 Pauwels Eric · CIK 0001323212 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,487 F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 1,197 RSUs from a January 29, 2020 grant of 4,790 RSUs. Read SEC document |
| January 25, 2021 Filed Jan 27, 2021 21:24 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 431 | $62.05 | $26,745.27 |
DisclosureSEC source: 0001179110-21-000873 · edgar.xml · nonDerivative · entry 1 Pauwels Eric · CIK 0001323212 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,849 F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 1,155 shares of restricted stock from a January 22, 2019 grant of 4,620 shares of restricted stock. Read SEC document |
| January 06, 2021 Filed Jan 8, 2021 22:16 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | GrantStock Option (Right to Buy) · Derivative | 59,500 | $0.00 Strike: $66.49 | $0.00 |
DisclosureSEC source: 0001179110-21-000472 · edgar.xml · derivative · entry 2 Pauwels Eric · CIK 0001323212 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,500 Underlying: Common Stock · 59,500 shares Expires 2031-01-05 F2 · derivative.exercise_date: This option was granted on January 6, 2021, and vests over four years, with 25% of the shares underlying the option vesting on January 6, 2022, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 6, 2022. Read SEC document |
| January 06, 2021 Filed Jan 8, 2021 22:16 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | GrantCommon Stock | 10,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-000472 · edgar.xml · nonDerivative · entry 1 Pauwels Eric · CIK 0001323212 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,280 F1 · shares: Restricted stock units granted on January 6, 2021 that vest in four equal installments over four years, commencing on January 6, 2022. Read SEC document |
| January 05, 2021 Filed Jan 7, 2021 21:59 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 778 | $62.37 | $48,523.86 |
DisclosureSEC source: 0001179110-21-000414 · edgar.xml · nonDerivative · entry 2 Pauwels Eric · CIK 0001323212 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,080 F3 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 2,300 shares of restricted stock from a January 3, 2018 grant of 9,200 shares of restricted stock. Read SEC document |
| January 05, 2021 Filed Jan 7, 2021 21:59 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 289 | $62.37 | $18,024.93 |
DisclosureSEC source: 0001179110-21-000414 · edgar.xml · nonDerivative · entry 1 Pauwels Eric · CIK 0001323212 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,858 F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 825 shares of restricted stock from a January 3, 2017 grant of 3,300 shares of restricted stock. F2 · balance_after: Includes 258 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2020 and 242 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2020. Read SEC document |
| November 03, 2020 Filed Nov 5, 2020 21:25 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 6,194 | $56.50 | $349,961.00 |
DisclosureSEC source: 0001179110-20-010836 · edgar.xml · nonDerivative · entry 1 Pauwels Eric · CIK 0001323212 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,647 F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on August 20, 2020. Read SEC document |
| April 16, 2020 Filed Apr 17, 2020 20:26 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | GrantStock Option (Right To Buy) · Derivative | 50,000 | $47.49 Strike: $47.49 | $2,374,500.00 |
DisclosureSEC source: 0001070081-20-000078 · wf-form4_158715514886804.xml · derivative · entry 2 Pauwels Eric · CIK 0001323212 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2030-04-15 F2 · derivative.exercise_date: This option was granted on April 16, 2020 and vests over four years, with 25% of the shares underlying the option vesting on April 16, 2021, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning July 16, 2021. Read SEC document |
| April 16, 2020 Filed Apr 17, 2020 20:26 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001070081-20-000078 · wf-form4_158715514886804.xml · nonDerivative · entry 1 Pauwels Eric · CIK 0001323212 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,841 F1 · shares: Restricted stock units granted on April 16, 2020 that vest in four equal installments over four years, commencing on April 16, 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.